Renalytix PLC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
OQB
RNLXY
Renalytix PLCRenalytix plc has scheduled its 2024 Annual General Meeting for December 19, 2024, to address key resolutions including financial reports, director compensation, auditor appointments, and share authorizations.
OQB
RNLXY
Renalytix PLCRenalytix is convening a General Meeting on October 31, 2024, to seek shareholder approval for resolutions including share allotment, director appointment, and disapplication of pre-emption rights to support the company's fundraising and strategic initiatives.
OQB
RNLXY
Renalytix PLCRenalytix plc is convening a general meeting on April 22, 2024, to seek shareholder approval for resolutions related to share allotment and disapplication of pre-emption rights to bolster the company's financial position and strategic flexibility.